Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
SVP, General Counsel · BeOne Medicines Ltd. · American Depositary Shares
Option exercise — administrative, little informational value
$20K reported value · new position
Disclosed 1 business day after execution (deadline: 2)
3 prior trades recorded in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Gift | G | — 1,183 sh | Nov 12, 2026 traded Nov 9, 2026 | |
| 24 | TITUS BENJAMIN BALLPrincipal Accounting Officer | Option exercise | M | $108K 679 sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 12 | TITUS BENJAMIN BALLPrincipal Accounting Officer | Option exercise | M | $183K 880 sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 43 | TITUS BENJAMIN BALLPrincipal Accounting Officer | Open-market sale | SELL | $11K 26 sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 49 | TITUS BENJAMIN BALLPrincipal Accounting Officer | Open-market sale | SELL | $622K 1,533 sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 9 | TITUS BENJAMIN BALLPrincipal Accounting Officer | Option exercise | M | — 8,827 sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 9 | TITUS BENJAMIN BALLPrincipal Accounting Officer | Option exercise | M | — 11.4K sh | Nov 10, 2026 traded Nov 6, 2026 | |
| 23 | Lee Chan HenrySVP, General Counsel | Open-market sale · 10b5-1 plan | SELL | $183K 455 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 26 | Lee Chan HenrySVP, General Counsel | Open-market sale · 10b5-1 plan | SELL | $264K 660 sh | Nov 9, 2026 traded Nov 5, 2026 | |
| 14 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $460K 1,280 sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 1 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Option exercise · 10b5-1 plan | M | $1.14M 31.0K sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 14 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $443K 1,239 sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 11 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $115K 320 sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 18 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $603K 1,681 sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 14 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $313K 880 sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 0 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Option exercise · 10b5-1 plan | M | — 403.4K sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 14 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $512K 1,440 sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 18 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $845K 2,331 sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 25 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $2.96M 8,148 sh | Oct 29, 2026 traded Oct 27, 2026 | |
| 25 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | Open-market sale · 10b5-1 plan | SELL | $1.03M 2,841 sh | Oct 29, 2026 traded Oct 27, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $19,641
Lee Chan Henry filed this Form 4 reporting a option exercise of ONC on Dec 11, 2025. It became public on Dec 12, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.